Yanling Chen - China Medical CFO, Vice President Executive Director
| 2M7C Stock | EUR 0.89 0.02 2.20% |
President
Ms. Chen Yanling serves as Chief Financial Officer, Vice President, Executive Director of China Medical System Holdings Limited. She was appointed as an executive Director on 18 December 2006. She joined the Group in 1995 and has remained with the Group since then. Ms. Chen is responsible for the Groups financial management, investor relations affairs and office administration. She received EMBA from the International EastWest University and is a senior accountant. Ms. Chen was awarded the Top Place of 2016 AllAsia Best CFO in Healthcare and Pharmaceutical Industry 2016 by the Institutional Investor magazine in July 2016. She earned the honour for the fifth time consecutively. since 2006.
| Age | 53 |
| Tenure | 19 years |
| Phone | 852 2369 7678 |
| Web | https://www.cms.net.cn |
China Medical Management Efficiency
The company has return on total asset (ROA) of 0.1324 % which means that it generated a profit of $0.1324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.243 %, meaning that it generated $0.243 on every $100 dollars invested by stockholders. China Medical's management efficiency ratios could be used to measure how well China Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | PRESIDENT Age | ||
| Adam Pollitzer | NMI Holdings | 43 | |
| Andrew Peyton | Superior Plus Corp | 55 | |
| William Leatherberry | NMI Holdings | 52 | |
| John Swenson | NMI Holdings | N/A | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 |
China Medical System Leadership Team
Elected by the shareholders, the China Medical's board of directors comprises two types of representatives: China Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Medical's management team and ensure that shareholders' interests are well served. China Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yanling Chen, CFO, Vice President Executive Director | ||
| Kong Lam, Executive Chairman of the Board, CEO and Presidentident | ||
| Wai Wong, Chief Technical Officer | ||
| Sanyan Wu, Company Secretary | ||
| Hongbing Chen, COO, Vice President Executive Director |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.37 % | |||
| Current Valuation | 3.65 B | |||
| Shares Outstanding | 2.45 B | |||
| Shares Owned By Insiders | 49.55 % | |||
| Shares Owned By Institutions | 19.25 % | |||
| Price To Earning | 7.18 X | |||
| Price To Book | 2.11 X |
Currently Active Assets on Macroaxis
Other Information on Investing in China Stock
China Medical financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medical security.